J I O Craig
Overview
Explore the profile of J I O Craig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gudgin E, Besser M, Craig J
Int J Lab Hematol
. 2008 Jan;
30(1):65-7.
PMID: 18190470
Bone marrow aspiration and biopsy can be a painful procedure. Sedation techniques may make this investigation more acceptable to patients, but have the potential to cause life-threatening complications, as well...
2.
Cooke L, Bowles K, Craig J, Sule O
J Clin Pathol
. 2006 Aug;
59(9):993-4.
PMID: 16935976
A 47-year-old fishmonger presented with a history of weight loss and lethargy. On investigation he was found to have myeloma. He presented again before follow up, with a 3-day history...
3.
Bord S, Frith E, Ireland D, Scott M, Craig J, Compston J
Bone
. 2005 Mar;
36(5):812-9.
PMID: 15794927
We have previously reported evidence that megakaryocytes may play a role in bone remodeling, possibly by interactions with cells at the bone surface. To investigate the direct effects of megakaryocytes...
4.
Bord S, Frith E, Ireland D, Scott M, Craig J, Compston J
Br J Haematol
. 2004 Jul;
126(2):244-51.
PMID: 15238146
To investigate the mechanisms by which megakaryocytes (MKs) may influence bone remodelling, CD34(+) cells were cultured for 6, 9 and 12 d with or without 17beta-oestradiol (E) and immunolocalized for...
5.
Orleans-Lindsay J, Deru A, Craig J, Prentice H, Lowdell M
Clin Exp Immunol
. 2003 Aug;
133(3):467-75.
PMID: 12930376
The existence of an immune based graft-versus-leukaemia (GvL) effect highlighted the prospect of managing relapsed leukaemias with T cell-based adoptive immunotherapy. Thus, various strategies have been explored for the in...
6.
Tauro S, Shankaranarayana P, Nitu-Whalley I, Duncan N, Begum G, Craig J, et al.
Bone Marrow Transplant
. 2003 Jul;
32(3):273-8.
PMID: 12858198
Stem cell transplantation (SCT) may be the only curative option for patients with relapsed or refractory leukaemia, that is, high-risk (HR) leukaemia. Several salvage regimens have been used to cytoreduce...
7.
OConnell B, Craig J, Marcus R, Ludlam H
Clin Lab Haematol
. 2002 Oct;
24(5):317-9.
PMID: 12358895
No abstract available.
8.
Dang R, Anthony R, Craig J, Leonard R, Parker A
Mol Pathol
. 2002 May;
55(3):177-81.
PMID: 12032228
Background/aims: Peripheral blood progenitor cell (PBPC) transplantation is frequently used in the treatment of malignant diseases, but contamination of the graft by tumour cells is a real concern and may...